Search

Your search keyword '"Montserrat Andreu"' showing total 161 results

Search Constraints

Start Over You searched for: Author "Montserrat Andreu" Remove constraint Author: "Montserrat Andreu" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
161 results on '"Montserrat Andreu"'

Search Results

1. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

2. Narrow-band imaging and high-definition white-light endoscopy in patients with serrated lesions not fulfilling criteria for serrated polyposis syndrome: a randomized controlled trial with tandem colonoscopy

3. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

4. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry

5. Predictors of Metachronous Risk Polyps After Index Colonoscopy

6. Meat intake, cooking methods and doneness and risk of colorectal tumours in the Spanish multicase-control study (MCC-Spain)

7. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study

8. Narrow band imaging and white light endoscopy in the characterization of a polypectomy scar: A single-blind observational study

9. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program

10. TFAP2E Methylation and Expression Status Does Not Predict Response to 5FU-based Chemotherapy in Colorectal Cancer

11. Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients

12. Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

13. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

14. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment

15. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

16. Treatment of Colorectal Cancer with Unresectable Metastasis with Chemotherapy Without Primary Tumour Resection: Analysis of Tumour-related Complications

17. Tratamiento del cáncer colorrectal con metástasis irresecables con quimioterapia sin resección del primario: análisis de las complicaciones relacionadas con el tumor

18. Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test

19. Impact of Current Smoking on the Clinical Course of Microscopic Colitis

20. Accuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies?

21. Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study

22. Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer

23. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration

24. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening

25. Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience

26. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

27. 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer

28. Su1745 - Predictive Value of Fecal Hemoglobin Levels in Consecutive Rounds in a Population Screening Program for Colorrectal Cancer (CRC)

29. Adenocarcinoma esofágico y esófago de Barrett. Adenocarcinoma gástrico y Helicobacter pylori

30. Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program

31. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

32. Detection of Metachronous Neoplasms in Colorectal Cancer Patients: Identification of Risk Factors

33. Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer

34. Identification of MYH Mutation Carriers in Colorectal Cancer: A Multicenter, Case-Control, Population-Based Study

35. Performance of Different Microsatellite Marker Panels for Detection of Mismatch Repair–Deficient Colorectal Tumors

36. Endosonographic and manometric evaluation of internal anal sphincter in patients with chronic anal fissure and its correlation with clinical outcome after topical glyceryl trinitrate therapy

38. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer

39. Clinical Performance of Original and Revised Bethesda Guidelines for the Identification of MSH2/MLH1 Gene Carriers in Patients with Newly Diagnosed Colorectal Cancer: Proposal of a New and Simpler Set of Recommendations

40. Adaptation to Spanish Language and Validation of the Fecal Incontinence Quality of Life Scale

41. Cyclooxygenase 2 Expression in Colorectal Cancer with DNA Mismatch Repair Deficiency

42. Applicability of the Rockall score in patients undergoing endoscopic therapy for upper gastrointestinal bleeding

43. Helicobacter pylori y cáncer gástrico: relación entre el subtipo histológico y la localización del tumor

44. Estudio ecográfico y manométrico del esfínter anal interno en individuos con fisura anal crónica

46. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain

47. Mo1685 Rate of Detection of Serrated Lesions in Proximal Colon by Simulated Sigmoidoscopy: Comparison With Colonoscopy and Faecal Immunochemical Testing in a Multicentre, Pragmatic, Randomised Controlled Trial

48. BMPR1Amutations in early-onset colorectal cancer with mismatch repair proficiency

49. Impact Of Adenoma Surveillance Guidelines On The Future Demand Of Colonoscopies Associated To A Population-Based Colorectal Cancer Screening Program

50. Postpolypectomy surveillance in patients with adenomas and serrated lesions: a proposal for risk stratification in the context of organized colorectal cancer-screening programs

Catalog

Books, media, physical & digital resources